drug
mNEXSPIKE
Marketedupdated 3mo agoby $MRNA Moderna, Inc.
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
News(1)
- Moderna maintains 10% growth target despite Phase 3 norovirus missModerna’s norovirus vaccine failed in a Phase 3 trial, but the company still has faith in an ambitious revenue growth target thanks to ex-U.S. vaccine sales and a unanimous FDA adcomm win for mFLUS…biospace · 14d ago
Data sources
last refreshed 27m ago
Found something off?
comments(0)
5-min edit window · permanent after that